rs2285477

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002470.4(MYH3):​c.3574G>A​(p.Ala1192Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.749 in 1,613,298 control chromosomes in the GnomAD database, including 460,038 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1192M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.69 ( 37317 hom., cov: 27)
Exomes 𝑓: 0.75 ( 422721 hom. )

Consequence

MYH3
NM_002470.4 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.761

Publications

36 publications found
Variant links:
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.30933E-6).
BP6
Variant 17-10638198-C-T is Benign according to our data. Variant chr17-10638198-C-T is described in ClinVar as Benign. ClinVar VariationId is 129658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH3NM_002470.4 linkc.3574G>A p.Ala1192Thr missense_variant Exon 27 of 41 ENST00000583535.6 NP_002461.2 P11055Q5GJ67
MYH3XM_011523870.4 linkc.3574G>A p.Ala1192Thr missense_variant Exon 27 of 41 XP_011522172.1 P11055
MYH3XM_011523871.3 linkc.3574G>A p.Ala1192Thr missense_variant Exon 27 of 41 XP_011522173.1 P11055
MYH3XM_047436127.1 linkc.3574G>A p.Ala1192Thr missense_variant Exon 29 of 43 XP_047292083.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH3ENST00000583535.6 linkc.3574G>A p.Ala1192Thr missense_variant Exon 27 of 41 5 NM_002470.4 ENSP00000464317.1 P11055
MYHASENST00000579914.2 linkn.705+24321C>T intron_variant Intron 4 of 4 4
MYHASENST00000584139.2 linkn.1041+24321C>T intron_variant Intron 7 of 8 3

Frequencies

GnomAD3 genomes
AF:
0.693
AC:
104795
AN:
151322
Hom.:
37289
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.648
Gnomad ASJ
AF:
0.752
Gnomad EAS
AF:
0.380
Gnomad SAS
AF:
0.613
Gnomad FIN
AF:
0.742
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.796
Gnomad OTH
AF:
0.689
GnomAD2 exomes
AF:
0.687
AC:
172652
AN:
251444
AF XY:
0.695
show subpopulations
Gnomad AFR exome
AF:
0.568
Gnomad AMR exome
AF:
0.556
Gnomad ASJ exome
AF:
0.755
Gnomad EAS exome
AF:
0.374
Gnomad FIN exome
AF:
0.749
Gnomad NFE exome
AF:
0.789
Gnomad OTH exome
AF:
0.719
GnomAD4 exome
AF:
0.755
AC:
1103404
AN:
1461860
Hom.:
422721
Cov.:
109
AF XY:
0.753
AC XY:
547392
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.553
AC:
18512
AN:
33480
American (AMR)
AF:
0.568
AC:
25394
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.753
AC:
19682
AN:
26136
East Asian (EAS)
AF:
0.382
AC:
15167
AN:
39700
South Asian (SAS)
AF:
0.630
AC:
54375
AN:
86256
European-Finnish (FIN)
AF:
0.754
AC:
40265
AN:
53390
Middle Eastern (MID)
AF:
0.627
AC:
3618
AN:
5768
European-Non Finnish (NFE)
AF:
0.794
AC:
882422
AN:
1112010
Other (OTH)
AF:
0.728
AC:
43969
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
20977
41955
62932
83910
104887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20496
40992
61488
81984
102480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.693
AC:
104876
AN:
151438
Hom.:
37317
Cov.:
27
AF XY:
0.685
AC XY:
50617
AN XY:
73936
show subpopulations
African (AFR)
AF:
0.567
AC:
23368
AN:
41226
American (AMR)
AF:
0.648
AC:
9855
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
2603
AN:
3462
East Asian (EAS)
AF:
0.381
AC:
1939
AN:
5084
South Asian (SAS)
AF:
0.612
AC:
2925
AN:
4776
European-Finnish (FIN)
AF:
0.742
AC:
7768
AN:
10472
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.796
AC:
54056
AN:
67918
Other (OTH)
AF:
0.694
AC:
1455
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1482
2964
4446
5928
7410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.750
Hom.:
142439
Bravo
AF:
0.676
TwinsUK
AF:
0.804
AC:
2981
ALSPAC
AF:
0.791
AC:
3048
ESP6500AA
AF:
0.574
AC:
2529
ESP6500EA
AF:
0.789
AC:
6787
ExAC
AF:
0.690
AC:
83758
Asia WGS
AF:
0.545
AC:
1901
AN:
3478
EpiCase
AF:
0.789
EpiControl
AF:
0.782

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32315303) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Freeman-Sheldon syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, type 2B3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Distal arthrogryposis type 2B1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.2
DANN
Benign
0.97
DEOGEN2
Benign
0.30
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.068
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.0000083
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.95
L
PhyloP100
-0.76
PrimateAI
Benign
0.31
T
Sift4G
Benign
0.52
T
Polyphen
0.014
B
Vest4
0.0080
MPC
0.25
ClinPred
0.0016
T
GERP RS
-2.1
Varity_R
0.027
gMVP
0.15
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2285477; hg19: chr17-10541515; COSMIC: COSV56862237; API